GenMark Dx's mission is to become the market leader in providing high value, simple to perform, clinically relevant multiplex molecular tests to aid in the diagnosis of disease and the selection and dosing of therapies.
For investor information, please contact IR@genmarkdx.com.
Feb 24, 2015 at 4:30 PM ET
GenMark Diagnostics Fourth Quarter Earnings
Jan 13, 2015 at 9:30 AM PT
2015 J.P. Morgan Healthcare Conference